Skip to content

To compare and analyze the effectiveness, safety and economy of different opioids for postoperative analgesia in bariatric surgery patients

To compare and analyze the effectiveness, safety and economy of different opioids for postoperative analgesia in bariatric surgery patients

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500110146
Enrollment
Unknown
Registered
2025-10-09
Start date
2025-10-12
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative analgesia in patients undergoing bariatric surgery

Interventions

Morphine group:The morphine loading dose was 5.0 mg before suturing, and 125mg of morphine was diluted to 100ml with 0.9% normal saline.
Sufentanil group:The load dose of sufentanil injection was 5.0ug before suturing, 125ug sufentanil +0.9% normal saline was diluted to 100ml.
Oliceridine group:Oliceridine fumarate injection was given at a loading dose of 1.0mg and 25mg oxelidine +0.9% normal saline diluted to 100ml before sutures.

Sponsors

Central Hospital Affiliated to Shandong First Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Voluntarily sign informed consent, fully understand the purpose and significance of this test, and voluntarily comply with this test procedure; 2. Laparoscopic weight loss surgery under general anesthesia should be performed at an appropriate time, and the operation duration should be >=1h; 3. 18 years old 27.5 kg/m² combined with obesity-related diseases, or simply BMI > 32.5 kg/m²; 5. ASA is graded as I to II.

Exclusion criteria

Exclusion criteria: 1. A history of vestibular dysfunction or dizziness, nausea, retching, and vomiting in the week before screening; 2. Previous psychiatric diseases (such as schizophrenia, depression, etc.) and cognitive dysfunction, or a history of epilepsy, Parkinson's syndrome; 3. Known prior allergy to opioids and other drugs that may be used during the trial, such as antiemetics; 4. Continuous use of opioid analgesics for any reason for more than 10 days in the 3 months prior to randomization, or the last time the drug was administered shorter than the 5-half-life of the drug; 5. Pregnant or lactating women.

Design outcomes

Primary

MeasureTime frame
Incidence of postoperative nausea and vomiting within 24 h;

Secondary

MeasureTime frame
Percentage of subjects who did not use remedial analgesics after surgery;;Time of first use of remedial analgesics, number of remedial analgesics within 24 h, cumulative use of remedial analgesics;;The frequency and severity of nausea at 2 hours, 6 hours, 12 hours and 24 hours after surgery;The frequency and severity of vomiting at 2 hours, 6 hours, 12 hours and 24 hours post-operation;The number of postoperative antiemetic drug uses and cumulative dose;Ramsay sedation scores at 2 hours, 6 hours, 12 hours and 24 hours after the operation;The frequency and duration of respiratory depression within 24 hours;The number of PCA compressions within 24 hours;The time when the resting NRS was first reduced to = 3 and the time when the cough NRS was first reduced to = 3;Length of hospital stay and total cost;Patient and doctor satisfaction scores (on a scale of 0 to 10);

Countries

China

Contacts

Public ContactFanjun Meng

Central Hospital Affiliated to Shandong First Medical University

mfja@sina.com+86 153 1881 6233

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026